Floatz logo

L-Carnitine L-Tartrate

Overweight and Obesity

Société des Produits Nestlé (SPN)N/AActive
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
81/ 100

Competitive context

26 Active assets in the Overweight and Obesity cohort.

Asset / SponsorPhaseRating
da-302168s
Chendu DIAO Pharmaceutical Group CO., LTD.
Phase 3BB
Polyglucosamine Glucomannan Normal Dose
Heilpflanzenwohl AG
Phase 4BB
POTASSIUM CATION
Brigham and Women's Hospital
Phase 4BB
CYANOCOBALAMINUM
The University of Texas Health Science Center, Houston
Phase 4BB
Chlorthalidone
Brigham and Women's Hospital
Phase 4BB

View all 47 →

Same molecule, other indications

L-Carnitine L-Tartrate is also rated in:

chemotherapy-induced toxicityDormant
B
Indicative ·
60 / 100
View asset →
toxic encephalopathyDormant
B
Indicative ·
60 / 100
View asset →
Non-alcoholic Fatty Liver Disease (NAFLD)Dormant
CCC
Indicative ·
55 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →